Around 10,500 new bladder cancer cases in the UK every year (2017-2019).
Deaths
5,800 deaths from bladder cancer, 2021-2023, UK.
Survival
42.3% survive bladder cancer for 10 or more years, (2018) UK.
Preventable cases
49% of bladder cancer cases are preventable, UK, 2015
There are around 10,500 new bladder cancer cases in the UK every year, that's 29 every day (2017-2019).
Bladder cancer is the 11th most common cancer in the UK, accounting for 3% of all new cancer cases (2017-2019).
In females in the UK, bladder cancer is the 17th most common cancer, with around 2,800 new cases every year. That's 2% of all new female cancer cases in the UK (2017-2019).
In males in the UK, bladder cancer is the 7th most common cancer, with around 7,600 new cases every year. That's 4% of all new male cancer cases in the UK (2017-2019).
Incidence rates for bladder cancer in the UK are highest in people aged 85 to 89 (2017-2019).
Each year almost three-fifths (56%) of all new bladder cancer cases in the UK are diagnosed in people aged 75 and over (2017-2019).
Since the early 1990s, bladder cancer incidence rates have decreased by more than two-fifths (42%) in the UK. Rates in females have decreased by more than two-fifths (42%), and rates in males have decreased by almost half (46%) (2017-2019).
Over the last decade, bladder cancer incidence rates have decreased by around a seventh (15%) in the UK. Rates in females have decreased by a seventh (14%), and rates in males have decreased by around a sixth (18%) (2017-2019).
Over the last decade, bladder cancer incidence rates have decreased by almost a sixth (16%) in the UK. Rates in females have decreased by around a seventh (15%), and rates in males have decreased by around a sixth (18%) (2017-2019).
Bladder cancer incidence rates are projected to fall by 14% in the UK between 2023-2025 and 2038-2040.
There could be around 10,700 new cases of bladder cancer every year in the UK by 2038-2040, projections suggest.
Bladder cancer incidence rates in England in females are 47% higher in the most deprived quintile compared with the least, and in males are 23% higher in the most deprived quintile compared with the least (2013-2017).
Around 980 cases of bladder cancer each year in England are linked with deprivation (around 370 in females and around 610 in males).
Incidence rates for bladder cancer are lower in the Asian and Black ethnic groups, compared with the White ethnic group, in England (2013-2017). See our publication Cancer Incidence by Broad Ethnic Group for more details.
An estimated 69,100 people who had previously been diagnosed with bladder cancer were alive in the UK at the end of 2010.
There are around 5,800 bladder cancer deaths in the UK every year, that's 16 every day (2021-2023).
Bladder cancer is the 9th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2021-2023).
In females in the UK, bladder cancer is the 13th most common cause of cancer death, with around 1,800 deaths every year. That's 2% of all female cancer deaths in the UK (2021-2023).
In males in the UK, bladder cancer is the 7th most common cause of cancer death, with around 3,900 deaths every year. That's 4% of all male cancer deaths in the UK (2021-2023).
Mortality rates for bladder cancer in the UK are highest in people aged 90+ (2021-2023).
Each year almost three-quarters (73%) of bladder cancer deaths in the UK are in people aged 75 and over (2021-2023).
Since the early 2000s bladder cancer mortality rates have decreased by around a seventh (15%) in the UK. Rates in females have decreased by around a seventh (15%), and rates in males have decreased by around a fifth (21%) (2021-2023).
Over the last decade, bladder cancer mortality rates have decreased by around a twentieth (6%) in the UK. Rates in females have decreased by around a twentieth (6%), and rates in males have decreased by almost a tenth (8%) (2021-2023).
More than 4 in 10 (42.3%) people diagnosed with bladder cancer in the UK survive their disease for ten years or more, it is predicted (2018).
Bladder cancer ten-year survival in the UK is lower in females than in males (2018).
Almost 1 in 2 (48.3%) females in the UK diagnosed with bladder cancer aged 15-44 survive their disease for ten years or more, compared with almost 1 in 4 (23.1%) females diagnosed aged 75-99 (2018).
Around 2 in 3 (67.1%) men in the UK diagnosed with bladder cancer aged 15-44 survive their disease for ten years or more, compared with almost 4 in 10 (37.1%) men diagnosed aged 75-99 (2018).
Bladder cancer survival has increased in the last 50 years in the UK.
In the 1970s, more than 1 in 3 (35.4%) people diagnosed with bladder cancer survived their disease beyond ten years, by 2018 it was more than 4 in 10 (42.3%).
Almost 6 in 10 (55.6%) people in England diagnosed with bladder cancer in the least deprived group survive their disease for five years or more, compared with almost half (46.1%) of people in the most deprived group (2016-2020).
Five-year relative survival for bladder cancer is above or similar to the European average in England, Wales and Northern Ireland, but below the European average in Scotland.
For bladder cancer, like other cancer sites, survival trends reflect a combination of changes in treatment and stage distribution. These factors themselves can vary by age, sex and deprivation.
Further survival statistics by stage can be found on the Early Diagnosis Data Hub and information on treatments for cancer can be found here.
A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
1 in 130 UK females and 1 in 55 UK males will be diagnosed with bladder cancer in their lifetime (born in 1961).
49% of bladder cancer cases in the UK are preventable.
45% of bladder cancer cases in the UK are caused by smoking.
6% of bladder cancer cases in the UK are caused by workplace exposures.
2% of bladder cancer cases in the UK are caused by ionising radiation.
See our Early Diagnosis Data Hub; for statistics on routes to diagnosis and screening uptake/coverage (for relevant cancer types)
For the most up-to-date statistics on early diagnosis and other metrics see our publications
Bladder cancer treatment
See our Treatment Data Hub which gathers information and statistics across a number of cancer treatment measures, including proportions of treatments given over time and detailed data on radiotherapy delivery. You can also ”view overviews of many national cancer site audits, split by site and country.
Statistics by cancer type
View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ.
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.
